Semper Paratus extends BC deadline to Dec 2023; $332M redeemed, trust reduced to $25M

Tevogen Bio Holdings Inc.

Shareholders approved charter amendment extending business combination deadline from Feb 8, 2023 to Dec 15, 2023.
Holders of 32,116,947 public shares elected redemption, receiving ~$332M ($10.34/share) from trust.
Post-redemption, trust account balance is ~$25M with only 2,383,053 public shares outstanding.
Class B shareholders converted all 11,983,333 Class B shares to Class A shares on a 1-for-1 basis.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Tevogen Bio Holdings Inc.: Approved an amendment to extend the deadline for consummating an initial business combination from February 8, 2023 to December 15, 2023 (effective 2023-02-03).

Change: charter amendment
Effective: 2023-02-03

Exact text from the filing

the shareholders of the Company approved an amendment (the “Charter Amendment”) to the Company’s Amended and Restated Memorandum and Articles of Association to extend the date by which the Company must consummate an initial business combination from February 8, 2023 to December 15, 2023. Under Cayman Islands law, the Charter Amendment took effect upon approval by the shareholders.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

Tevogen Bio Holdings Inc. shareholders approved Approval of Charter Amendment at the 2023-02-03 meeting.

Proposal: charter amendment
Outcome: passed
Meeting: 2023-02-03

Exact text from the filing

otes: For Against Abstain 35,386,187 4,266,453 0 The adjournment proposal was not presented to the shareholders because there were sufficient votes to approve the Charter Amendment.

View on SEC.gov

24 governance changes filed in the last 30 days. Browse all governance changes →

Tevogen Bio Holdings Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-017639

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.